Brought to you by

Modern Biosciences gets RA candidates from Univ. of Aberdeen
19 Nov 2007
Executive Summary
The University of Aberdeen licensed Modern Biosciences PLC (acquires early-stage compounds) exclusive worldwide rights to develop preclinical oral small-molecule therapeutics for rheumatoid arthritis, osteoporosis, and inflammatory conditions.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com